Simple Summary The cancer-immunity cycle is characterized by various stimulatory and
inhibitory factors, which together regulate the immune response and halt the extreme …

While colorectal cancers (CRC) are paradigmatic tumors invaded by effector memory
lymphocytes, the mechanisms accounting for the relative resistance of MSI negative CRC to …

The immune system, and in particular T cells, can be harnessed to treat cancer. Several
bispecific T cell engaging antibodies of the BiTE® format are in early or late-stage clinical …

The ability of the immune system to precisely target and eliminate aberrant or infected cells
has long been studied in the field of infectious diseases. Attempts to define and exploit these …

This work provides a succinct insight into the recent developments in electrochemical
quantification of vital biomedical markers using hybrid metallic composite nanostructures …

Metastasis is a highly complicated and sequential process in which primary cancer spreads
to secondary organic sites. Liver is a well‐known metastatic organ from colorectal cancer …

Decades of research are now leading to therapeutics that target the molecular mechanisms
of the cancer-specific immune response. These therapeutics include tumor antigen …

Despite the availability of technological advances in traditional anti-cancer therapies, there
is a need for more precise and targeted cancer treatment strategies. The wide-ranging …

Breast cancer is considered the second-leading cancer after lung cancer and is the most
prevalent cancer among women globally. Currently, cancer immunotherapy via vaccine has …

So far, a number of tumour‐associated antigens (TAA s), such as heat shock proteins, alpha‐
fetoprotein, carcino‐embryonic antigen and others have been identified in a variety of …